Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Damian Szczesny"'
Autor:
Tomasz Antonowski, Adam Osowski, Damian Szczesny, Joanna Szablińska-Piernik, Jerzy Juśkiewicz, Lesław Lahuta, Andrzej Rynkiewicz, Joanna Wojtkiewicz
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11246
Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from t
Autor:
Tomasz, Antonowski, Adam, Osowski, Damian, Szczesny, Joanna, Szablińska-Piernik, Jerzy, Juśkiewicz, Lesław, Lahuta, Andrzej, Rynkiewicz, Joanna, Wojtkiewicz
Publikováno v:
International journal of molecular sciences. 23(19)
Publikováno v:
Pharmacological Reports
Background Human recombinant erythropoietin (rHuEPO) is often used in the treatment of diseases associated with a decreased production of red blood cells (RBC), such as chronic renal failure. rHuEPO is typically administered as an intravenous or subc
Autor:
Damian Szczesny, Roman Kaliszan, Paweł Wiczling, Michał J. Markuszewski, Arlette Yumba Mpanga, Emilia Daghir-Wojtkowiak
Publikováno v:
Journal of separation science. 40(24)
Analysis of time series data addresses the question on mechanisms underlying normal physiology and its alteration under pathological conditions. However, adding time variable to high-dimension, collinear, noisy data is a challenge in terms of mining
Autor:
Roman Kaliszan, Julia Jacyna, Danuta Siluk, Damian Szczesny, Ewa Bartosińska, Małgorzata Patejko
Publikováno v:
Biomedical chromatography : BMC. 32(2)
Trigonelline is a pyridine alkaloid found in fenugreek seeds and coffee beans. Most of the previous studies are concerned with the quantification of trigonelline along with other constituents in coffee herbs or beverages. Only a few have focused on i
Autor:
Włodzimierz Płotek, Ewa Bednarek, Agnieszka Bienert, Katarzyna Buda, Agnieszka Kamińska, Artur Teżyk, Damian Szczesny, Czesław Żaba, Hanna Billert, Paweł Wiczling, Bartosz Kostrzewski, Edmund Grześkowiak, Roman Kaliszan
Publikováno v:
Pharmacological Reports. 66:143-152
Background This study evaluates the time-of-day effect on midazolam and 1-OH midazolam pharmacokinetics, and on the sedative pharmacodynamic response in rabbits. Also, circadian fluctuations in rabbits’ vital signs, such as the blood pressure, hear
Autor:
Edmund Grześkowiak, Krzysztof Przybyłowski, Agnieszka Bienert, Katarzyna Kut, Damian Szczesny, Emilia Plenzler, Joanna Tyczka, Roman Kaliszan, Paweł Wiczling
Publikováno v:
Journal of Pharmacokinetics and Pharmacodynamics
Despite the growing number of cancer cases and cancer surgeries around the world, the pharmacokinetics (PK) and pharmacodynamics (PD) of anesthetics used in this population are poorly understood. Patients operated due to cancer are usually in severe
Autor:
Lech Chmurzyński, Damian Szczesny, Roman Kaliszan, Joanna Makowska, Agnieszka Lichucka, Artur Giełdoń
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 968
For trigonelline, a quaternary-base pyridine alkaloid of presumed Alzheimer's disease-preventing activity, a method of determination has been proposed, based on the hydrophilic interaction chromatography (HILIC). That method might be applied to study
Autor:
Natalia Ratajczak, Iwona Zawidzka, Jan Matysiak, Włodzimierz Płotek, Agnieszka Bienert, Damian Szczesny, Paweł Wiczling, Zenon J. Kokot, Edmund Grześkowiak
Publikováno v:
Chronobiology international. 28(4)
This study evaluates the administration time-of-day effects on propofol pharmacokinetics and sedative response in rabbits. Nine rabbits were sedated with 5 mg/kg propofol at three local clock times: 10:00, 16:00, and 22:00 h. Each rabbit served as it
Autor:
J. Jose Corbalan, Robert F. Jacob, Damian Szczesny, R. Preston Mason, Tadeusz Malinski, Kinga Matysiak
Publikováno v:
BMC Pharmacology & Toxicology
Background Nebivolol is a third-generation beta-blocker used to treat hypertension. The vasodilation properties of nebivolol have been attributed to nitric oxide (NO) release. However, the kinetics and mechanism of nebivolol-stimulated bioavailable N